Treatment of Abdominal Tumors
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 195
Special Issue Editors
Interests: hepatocellular carcinoma; colon cancer; tumor immune microenvironment; neutrophils; macrophage
Special Issue Information
Dear Colleagues,
Abdominal tumors, including malignancies such as liver, pancreatic, colorectal, and gastric cancer represent, a significant clinical challenge due to their anatomical complexity and aggressive nature. These tumors often exhibit resistance to conventional treatments, necessitating the development of novel therapeutic strategies. Recent advancements in the treatment of abdominal tumors have focused on a multidisciplinary approach, integrating surgical innovations with targeted therapies and immunotherapy. The role of molecular and genetic profiling in personalizing treatment plans has also gained prominence, leading to improved outcomes for patients. However, despite these advances, challenges remain, particularly in overcoming treatment resistance and managing metastatic disease. This Special Issue aims to provide a comprehensive overview of current therapeutic strategies, highlight emerging research, and discuss future directions in the treatment of abdominal tumors. By bringing together insights from surgical oncology, molecular biology, and clinical research, this issue seeks to enhance our understanding of the mechanisms driving abdominal tumor progression and to explore innovative approaches for improving patient outcomes.
Dr. Hongji Zhang
Dr. Chengli Shen
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liver cancer
- pancreatic cancer
- colorectal cancer
- gastric cancer
- treatment resistance
- surgical oncology
- targeted therapy
- molecular mechanisms
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
